Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

BETASERC 24 TABLET 24 mg

Approval Number

SIN12235P

Drug Name

BETASERC 24 TABLET 24 mg

Product Name

BETASERC 24 TABLET 24 mg

Approval Date

March 24, 2003

Registrant

ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED

Licence Holder

ABBOTT LABORATORIES (SINGAPORE) PRIVATE LIMITED

Regulatory Information

Registrant

ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED

Licence Holder

ABBOTT LABORATORIES (SINGAPORE) PRIVATE LIMITED

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

N07CA01

ATC Item Name

betahistine

Manufacturer Information

Pharmaceutical Manufacturer

ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED

Manufacturers

Mylan Laboratories SAS

Active Ingredients

Ingredient Name

BETAHISTINE 2HCl

Strength

24 mg

Drug MonographBetahistine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy